Sales of MS and eczema drugs could top $4bn by 2022
Company nabs maintenance therapy use, but problems on breast cancer trial.
Algorithm accurately detects depression from brain scans in 75% of cases.
This week’s news
Former AZ chief David Brennan expected to take over as chairman in May.
MPs to discuss controversial plan in special debate.
MSD keeps pressure on BMS with EU classical Hodgkin lymphoma indication.
Trump could use executive powers to undermine system.
Company bolsters augmented reality division.
Amid opiate crisis, Purdue looks for abuse-deterrent alternatives.
Back reforms or else, says Trump.
VirtTuri aims to triage those with colds, coughs, flu, and hay fever.
Companies to sequence data from 500,000 volunteers from UK’s Biobank.
Recall follows two reports that allergy injection device failed.